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Noninvasive approaches for assessment of liver histology include routine laboratory tests and radiological evaluation.The purpose
of our study was to determine the utility of a simplified scoring system based on routinely evaluated ultrasound features for the
evaluation of chronic liver disease and correlate it with the histological findings. For this cross-sectional analytical study the datawas
collected prospectively by nonprobability purposive sampling technique. The ultrasound variables/parameters and their assigned
scoring system that was a modified version adopted from published literature were evaluated. Sensitivity, specificity, positive and
negative predictive values of the liver morphological score and combined score of liver morphology and sizes was determined using
stage and grade as reference standard. Our results show a high sensitivity and PPV of liver morphological sonographic evaluation
for the staging and grading of CLD respectively thus supporting it as a screening diagnostic strategy. Of the three liver morphology
variables, specificity of liver surface evaluation was highest for the stage of fibrosis and grade of inflammation. The simplified
ultrasound scoring system evaluated in our study is clinically relevant and reproducible for differentiating patients with CLD with
mild or no fibrosis from moderate to severe fibrosis.
1. Introduction
Thecommon causes of chronic liver disease are viral hepatitis,
alcohol abuse, and metabolic disorders. These result in
hepatocytes damage, the consequence of which may be liver
fibrosis, cirrhosis, and/or hepatocellular carcinoma [1]. The
disease is a substantial cause of morbidity and mortality
in the developing countries. Accurate evaluation of the
severity of disease is crucial for treatment planning, that is,
commencement of antiviral treatment and prognostication
[2].
Noninvasive approaches for assessment of liver histology
include routine laboratory tests like serum markers, liver
functions test, and radiological evaluation of liver. Liver
histological diagnosis based on needle biopsy determines
the inflammatory activity (grading), the extent of fibrosis
(staging), and other comorbidities [3]. But the procedure of
ultrasound guided liver biopsy is invasive with about 1% risk
of significant complications like postinterventional hemor-
rhage, bile leak, infection, and injury to adjacent organs with
less than 0.1% mortality [4]. Sampling errors may also be
encountered since the liver parenchymal damage in chronic
hepatitis is not homogeneous. In addition there is possibility
of inter- and intraobserver variability [5]. Imaging technolo-
gies, particularly ultrasound, are inexpensive, noninvasive,
readily available, and acceptable to the patient. It is routinely
utilized in evaluation of spectrum of chronic liver disease as it
provides useful information on themorphological alterations
of the liver and organs affected as a result of portal hyper-
tension; in addition color Doppler flow imaging provides
information regarding the liver hemodynamics. The other
imaging modalities like computerized tomography (CT) and
magnetic resonance imaging (MRI) are also helpful, but these
are expensive and require contrast administration [6]. A
number of ultrasound variables based on liver morphology,
hemodynamics, and different techniques of ultrasound like
simultaneous use of high and low frequency transducers
have been evaluated to predict the liver fibrosis stage with
variable accuracy.The purpose of our study was to determine
the utility of a simplified scoring system based on routinely
evaluated ultrasound features for the evaluation of chronic
liver disease and correlate it with the histological findings.
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Table 1: Ultrasound variable and scores.
Variables Score 0 Score 1 Score 2
Liver parenchymal echotexture Homogenous/fine Coarse Highly nonhomogenous/coarse
Liver surface Smooth Irregular Nodular
Liver edge (inferior margin right lobe) Sharp (acute) Blunted Rounded
Liver size Normal Enlarged (>15 cm midclavicular line)
Shrunken (<10 cm in mid
clavicular line)
Portal vein diameter Normal Dilated (>13mm)
Spleen size Normal Enlarged (>13 cm)
The concept is to evolve an effective, simple to understand,
applicable, and radiologically relevant scoring system for
evaluation of the extent of chronic liver disease.
2. Material and Methods
This cross-sectional analytical study was performed in the
Department of Radiology AKUH from January 2010 to
December 2011. The data was collected prospectively by
nonprobability purposive sampling technique. All patients
sent to the Radiology Department of Aga Khan University
Hospital for ultrasound guided liver biopsy were included.
Patients were excluded if the histopathology report of liver
biopsy was not available and if the biopsy was performed for
focal lesions or autoimmune liver disease. In addition patients
unfit for liver biopsy due to jaundice, ascites, and deranged
blood profiles were also excluded. Patients’ confidentiality
was guaranteed and maintained during the course of the
study.
Prior to the biopsy real time ultrasound using Toshiba
Nemio XG was performed for all patients using 3.5–5.0MHz
convex transducer by the radiologist on duty in the ultra-
sound interventional suit having at least 3 years of experience
in performing abdominal sonography. Ultrasound of the liver
was performed, both lobes of liver were evaluated, and a com-
bined impressionwas derived. In addition size of liver, spleen,
and portal vein was also assessed and noted. The ultrasound
parameters and scoring system were explained to examining
radiologist prior to the procedure and findings recorded on a
standard proforma.The ultrasound variables/parameters and
their assigned scoring system that was a modified version
adopted from the published literature are as depicted in
Table 1 [7, 8].
The sample for the liver biopsy was obtained from the
right lobe of liver-anterior segment using Bards Tru-Cut
Biopsy 18 gauge needle. The specimen was reviewed by
histopathologist unaware of the ultrasound findings.
The histopathology reports were reviewed through the
hospital information system and assessed for grading and
staging of the biopsy specimen which was analyzed using
the Batts and Ludwig scoring system. Grade evaluated the
degree and location of inflammation and stage assessing
the location and extent of fibrosis in the biopsy specimen.
According to the histopathology scoring system stage 0 was
described as no fibrosis and with increasing fibrosis a score
of 4 was assigned for cirrhosis. For the grading score 0
described portal inflammation only and with increasing
lobular inflammation and necrosis, score of 4 denoting severe
diffuse hepatocellular damage with bridging necrosis [9].
For the purpose of analysis stage and grade 0 and 1 were
taken as mild or no disease and stages 2, 3, and 4 as moderate
to severe disease.
The ultrasound scoring system was also categorized as
“A” for liver morphological evaluation comprising of liver
surface, parenchymal echo texture, and edge and “B” for the
combined score of liver morphology as detailed above and
sizes evaluation of liver, spleen, and portal vein.
2.1. Sample Size Calculation. Calculated sensitivity of ultra-
sound for detecting chronic liver disease is 77% [10] with
confidence level of 95%, margin of error 10%, and calculated
sample size 𝑁 = 115. This was done by using the following
formula𝑁 = [𝑧2
1−𝛼/𝜀
(1 − 𝑃/𝜀
2
𝑃)].
2.2. Plan of Analysis. Data was entered and analyzed using
SPSS windows package version 19.0. Frequencies were cal-
culated, and proportions reported for categorical variables.
Mean and standard deviations calculated for quantitative
variable like age. Sensitivity, specificity, positive, and neg-
ative predictive values with 95% confidence intervals were
reported for ultrasound in detecting chronic liver disease in
the patients taking histopathology/biopsy as gold standard.
3. Results
The study population (𝑁 = 116) included predominantly
males, 74 (64%) with a mean age of 39.54 years ± SD 12.77,
range between 15 and 70 years. Data was collected of 116
patients prospectively over a period of two years from a
tertiary care center, the Aga Khan University Hospital. Out
of the 116 patients, 78 (67%) were hepatitis C reactive.
Sensitivity, specificity, positive and negative predicted
values of the liver morphological score denoted as “A” and
combined score of liver morphology and sizes denoted as “B”
was determined using stage and grade as reference standard
(Table 2).
Majority of patients 97 (84%) presented with normal liver
size, 11 (9%) presented with an enlarged liver, and 8 (7%)
presented with a liver smaller in size. The liver surface was
smooth in 71 (61%), while 32 (28%) showed amildly irregular
liver surface. 13 (11%) presentedwith an irregular liver surface.
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Table 2: Accuracy of US scoring system.
Histopathology Sensitivity Specificity PPV NPV
A = liver morphological score Stage 90.3% 47.7% 73.9% 75%
Grade 84.1% 44.1% 78.4% 53.6%
B = liver morphological score +
liver, spleen, and portal vein size
Stage 44.4% 88.6% 86.5% 49.4%
Grade 41.5% 91.2% 92% 39.2%
Table 3: (a) Diagnostic performance of US variables in predicting fibrosis/stage. (b) Diagnostic performance of US variables in predicting
grade.
(a)
Variable Sensitivity (95% CI∗) Specificity (95% CI∗) ∧PPV (95% CI∗) §NPV (95% CI∗) ¤P value
Liver edge 84.72 (0.74, 0.92) 61.36 (0.46, 0.75) 78.21 (0.67, 0.86) 71.05 (0.55, 0.84) 0.000
Liver surface 54.16 (0.42, 0.65) 86.36 (0.72, 0.94) 86.66 (0.72, 0.94) 53.52 (0.41, 0.65) 0.000
Liver texture 75 (0.63, 0.84) 66 (0.49, 0.79) 78.26 (0.66, 0.86) 61.7 (0.46, 0.75) 0.000
Liver size 12.5 (0.06, 0.22) 77.27 (0.61, 0.88) 47.3 (0.25, 0.70) 35.05 (0.26, 0.45) 0.149
Spleen size 9.72 (0.04, 0.19) 93.2 (0.80, 0.98) 70 (0.35, 0.91) 38.68 (0.29, 0.48) 0.589
Portal vein diameter 5.55 (0.01, 0.12) 100(∞) 100(∞) 39.28 (0.30, 0.48) 0.112
∧PPV: positive predictive value.
§NPV: negative predictive value.
(95% CI∗): 95% confidence internal.
¤
𝑃 value: chi-square test 𝑃 value.
(∞): Cannot be calculated because either of one cell contains a “zero.”
(b)
Variable Sensitivity (95% CI∗) Specificity (95% CI∗) ∧PPV (95% CI∗) §NPV (95% CI∗) ¤P value
liver edge 80.5 (0.70, 0.88) 64.71 (0.46, 0.79) 84.62 (0.74, 0.91) 57.89 (0.41, 0.73) 0.000
liver surface 51.22 (0.40, 0.62) 91.18 (0.75, 0.97) 93.33 (0.81, 0.98) 43.66 (0.32, 0.55) 0.000
liver texture 72 (0.61, 0.81) 70.6 (0.52, 0.84) 85.51 (0.74, 0.92) 51.06 (0.36, 0.65) 0.000
liver size 14.63 (0.08, 0.24) 79.41 (0.61, 0.90) 63.16 (0.38, 0.82) 27.83 (0.19, 0.38) 0.430
spleen size 9.76 (0.04, 0.18) 94.12 (0.78, 0.98) 80 (0.44, 0.96) 30.28 (0.22, 0.39) 0.499
portal vein diameter 4.88 (0.01, 0.12) 100(∞) 100(∞) 30.36 (0.22, 0.39) 0.190
∧PPV: positive predictive value.
§NPV: negative predictive value.
(95% CI∗): 95% confidence internal.
¤P value: chi-square test P value.
(∞): Cannot be calculated because either of one cell contains a “zero.”
Liver edge was sharp in 38 (33%), mildly blunted in 66
(57%), and rest 12 (10%) showed a blunted liver edge. Portal
vein was normal in 112 (97%) and dilated in the remaining of
the total sample.
Sensitivity, specificity, positive andnegative predicted val-
ues and 𝑃-value using chi-square test of the each ultrasound
variable were determined using stage and grade as reference
standard. {Tables 3(a) and 3(b)}.
4. Discussion
Chronic liver disease is a spectrum of disease manifestation
leading to cirrhosis. Current development and improvement
in the treatment and management options have stressed a
need for prompt diagnosis of CLD to identify asymptomatic
patients in a population that is high risk, for example, due to
high prevalence of viral hepatitis, and hence provide a better
patient outcome. Accurate estimation of the degree of hepatic
damage in fibrosis or cirrhosis before the compensation
becomes clinically evident is crucial for treatment, prognosis,
and surveillance. The noninvasive methods to assess features
of CLD include serologic fibrosis markers like fibro test,
aspartate aminotransferase-to-platelet ratio index (APRI),
and radiologic imaging [11]. These tests are regarded to be
perfect and ideal only if these are simple, accessible cheap,
and exhibit high accuracy.
In the present study we attempted to develop a simplified
scoring system based on ultrasound parameters routinely
evaluated in sonographic studies and likely to be affected
during the course of CLD like liver morphological appear-
ance and the dimension of liver, portal vein, and spleen. The
US scores were compared with the histopathological results
of the biopsy specimen. A number of studies have utilized
the ultrasound examination for the diagnosis and staging
of chronic liver disease making use of different techniques
like the conventional gray scale and Doppler [12, 13] to
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Table 4: Comparison with prior studies of validity of ultrasound score in the evaluation of chronic liver disease.
Study Number of patients Characteristics Sensitivity Specificity
Gaiani et al. [13] 1997 212
US scoring comprising of
seven morphological and
hemodynamic hepatic
parameters
82% 79%
Hung et al. [8] 2003 210
US scoring comprising of
liver surface, parenchyma,
vascular structure, and
spleen size
HBV-related cirrhosis
77.8%
HCV-related cirrhosis
82.4%
HBV-related cirrhosis
92.5%
HCV-related cirrhosis
70.7%
Choong et al. [15] 2012 156 Three hepatic featuresassessed
53% (combined score liver
surface and edge)
94% (combined score of
surface and texture)
Afzal et al. 2013 116 US scoring system based onsix variables
Liver morphology 90.3%
(stage)
84.1% (grade)
Liver morphology + size of
liver, spleen, and PV
44.4% (stage)
41.5% (grade)
Liver morphology 47.7%
(stage)
44.1% (grade)
Liver morphology + size of
liver, spleen, and PV
88.6% (stage)
91.2% (grade)
sophisticate technique of transient elastography and using
contrast agent [11, 14]. Gaiani et al. [13] investigated patient
with chronic liver disease for the presence of compensated
cirrhosis using ultrasound scoring system and achieved the
sensitivity and specificity of 78.7% and 80.2%, respectively. A
comparison of prior studies using ultrasound scores for the
evaluation of chronic liver disease is shown in Table 4.
Our results show a high sensitivity and PPV of liver
morphological sonographic evaluation for the staging and
grading of CLD, respectively, thus supporting it as a screening
diagnostic strategy. The two groups of liver fibrosis that
is mild/no fibrosis and moderate/severe fibrosis/cirrhosis
could be differentiated using this scoring system with high
sensitivity and PPV.This is likely to be related to the fact that
the simplified scoring system in the present study evaluated
the findings on a 3 level scale, that is, 0, 1, and 2 as compared to
other studies [15] where findings were evaluated on a 4-point
scale ranging from 0 to 4.
Of the three liver morphology variables, liver surface
evaluation depicted specificity of 86.3% for the stage of
fibrosis and 91.1% for the grade of inflammation. The result
is in keeping with other studies that showed a high specificity
of surface nodularity [16]. In this prospective study liver edge
was also found to have a high sensitivity and specificity for
detection of liver fibrosis and grades of inflammation and
differed from other studies in which liver edge was not found
to be specific for liver fibrosis evaluation [7].
In this study the cut-off value of the ultrasound score was
2 for liver morphology (category A) and 3 for combination
of morphology and sizes (category B). The liver morphology
score using 3 variables provided a sensitivity of 90.3%, but a
sensitivity of 44.4% was achieved when all 6 variables were
assessed and is lower than that reported by using 4 variables
[8]. The patients with clinically decompensated CLD were
excluded in the present study to maximize the efficacy of the
ultrasound examination. But in addition to the US signs for
assessing liver parenchyma, signs consistent with advanced
liver disease like enlarged spleen, shrunken liver, and por-
tal hypertension were also evaluated for their presence in
nonsymptomatic patients. The number of patients diagnosed
as stage IV fibrosis on histopathology in the present study
is 19 (16.4%), while on sonography the frequency of small
shrunken liver and splenomegaly is 8 (7%) and 10 (8.6%),
respectively.
This study has a few limitations. The study results show
high sensitivity, but the specificity is low, and hence there is a
need to come upwith further research to get better diagnostic
accuracy. This can be achieved by addressing factors such as
intra and inter observer variability, quality assurance of the
technique and equipment of ultrasound. Since liver histology
was taken as gold standard in this study, the possibility of
sampling errors and inter- and intraobserver variability in
assessment of biopsy specimen cannot be ruled out and may
have also affected our results.
Presence of hepatic steatosis significantly affects the liver
parenchymal appearance, but this finding was not assessed in
the US evaluation of the study group.
5. Conclusion
The simplified ultrasound scoring system evaluated in our
study is clinically relevant and reproducible for differentiating
patients with CLD with mild or no fibrosis to moderate to
severe fibrosis. Since we also evaluated the sensitivity of these
parameters for grading, it is also helpful in determining the
prognosis and best possible therapeutic option.
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